March 19, 2018
Study: Changes in intestines lead to reversal of diabetes after RYGB surgery
Editor's Note
Changes in gene expression in intestinal tissue of patients after Roux-en-Y gastric bypass (RYGB) surgery explain and predict blood glucose improvement and body weight loss, finds this study presented March 18 at the Endocrine Society’s annual meeting in Chicago.
The findings are based on the first 19 patients; 32 patients will be recruited for the full study.
This is the first study to link changes in intestinal biology to clinical improvement after bariatric surgery, the authors say.
Free Daily News
- Orthopedic surgery in 2025: Embracing innovation, preserving autonomy
- Medtronic, Zimmer Biomet challenge Intuitive Surgical’s robotic surgery dominance
- Anthem’s anesthesia time limit policy, reversal sparks new legislation
- Simple procedure or ‘surgery’? Questionable medical billing practices cause confusion
- Antitrust guideline withdrawal could dampen M&A, boost uncertainty for provider joint ventures
- Surgeons emphasize bariatric surgery benefits amid rising GLP-1 drug popularity
- Study: Geriatric surgery program improves outcomes, independence
- Milestone pig kidney transplant offers hope amid ethical, safety questions
- Fitch Ratings: Hospital credit outlook improves amid stabilizing margins
- Annual Leapfrog Group awards recognize top hospitals, ASCs
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement